ALK and inflammatory myofibroblastic tumor: Patients with metastatic IMT harboring ALK alterations can be successfully treated with ALK inhibitors.[10,11] However, treatment options are limited for patients with unresectable/advanced disease and for those with ALK-negative tumors.[12]